FIT-103

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameFIT-103
Drug Alias Nameantibody-based gene therapy (FIT Biotech)FIT-103
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsChikungunya Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFinland
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFIT Biotech Oyj Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFIT Biotech Oyj Plc
Active IndicationsN/A
Inactive IndicationsChikungunya Fever

Other Information

ATC CodeN/A
Related LinksN/A